Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Characteristics of humoral and cellular immunity to Salmonella typhi in residents of typhoid-endemic and typhoid-free regions.

Literature DB >> 3680988

Characteristics of humoral and cellular immunity to Salmonella typhi in residents of typhoid-endemic and typhoid-free regions.

J R Murphy¹, S Baqar, C Muñoz, L Schlesinger, C Ferreccio, A A Lindberg, S Svenson, G Losonsky, F Koster, M M Levine.

Abstract

Entities: Species

Mesh：

Substances：

Year: 1987 PMID： 3680988 DOI： 10.1093/infdis/156.6.1005

Source DB: PubMed Journal: J Infect Dis ISSN： 0022-1899 Impact factor: 5.226

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers?

Authors: Pietro Mastroeni; Omar Rossi
Journal: Infect Immun Date: 2020-09-18 Impact factor: 3.441

2. Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children.

Authors: S J Cryz; N Vanprapar; U Thisyakorn; T Olanratmanee; G Losonsky; M M Levine; S Chearskul
Journal: Infect Immun Date: 1993-03 Impact factor: 3.441

3. Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites.

Authors: D A Herrington; D F Clyde; J R Davis; S Baqar; J R Murphy; J F Cortese; R S Bank; E Nardin; D DiJohn; R S Nussenzweig
Journal: Bull World Health Organ Date: 1990 Impact factor: 9.408

Review 4. Immunology of gut mucosal vaccines.

Authors: Marcela F Pasetti; Jakub K Simon; Marcelo B Sztein; Myron M Levine
Journal: Immunol Rev Date: 2011-01 Impact factor: 12.988

5. Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.

Authors: C O Tacket; B Forrest; R Morona; S R Attridge; J LaBrooy; B D Tall; M Reymann; D Rowley; M M Levine
Journal: Infect Immun Date: 1990-06 Impact factor: 3.441

6. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.

Authors: J Y Wang; F R Noriega; J E Galen; E Barry; M M Levine
Journal: Infect Immun Date: 2000-08 Impact factor: 3.441

Characteristics of humoral and cellular immunity to Salmonella typhi in residents of typhoid-endemic and typhoid-free regions.

Review 1. Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers?

2. Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children.

3. Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites.

Review 4. Immunology of gut mucosal vaccines.

5. Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.

6. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.

7. Human cell-mediated immune responses to antigenic fractions of Salmonella typhi.

8. Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regions.

9. Immunogenicity of Salmonella typhi Ty21a vaccine for young children.

Review 10. Vaccination against typhoid fever: present status.